Detalhe da pesquisa
1.
Retrospective genetic testing (Traceback) in women with early-onset breast cancer after revised national guidelines: a clinical implementation study.
Breast Cancer Res Treat
; 205(3): 599-607, 2024 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-38491334
2.
Whole-body MRI surveillance in TP53 carriers is perceived as beneficial with no increase in cancer worry regardless of previous cancer: Data from the Swedish TP53 Study.
Cancer
; 129(6): 946-955, 2023 03 15.
Artigo
Inglês
| MEDLINE | ID: mdl-36601958
3.
Breast cancer survival in Nordic BRCA2 mutation carriers-unconventional association with oestrogen receptor status.
Br J Cancer
; 123(11): 1608-1615, 2020 11.
Artigo
Inglês
| MEDLINE | ID: mdl-32939053
4.
Refinement of breast cancer molecular classification by miRNA expression profiles.
BMC Genomics
; 20(1): 503, 2019 Jun 17.
Artigo
Inglês
| MEDLINE | ID: mdl-31208318
5.
High patient satisfaction with a simplified BRCA1/2 testing procedure: long-term results of a prospective study.
Breast Cancer Res Treat
; 173(2): 313-318, 2019 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-30311024
6.
Detection of circulating tumor cells and circulating tumor DNA before and after mammographic breast compression in a cohort of breast cancer patients scheduled for neoadjuvant treatment.
Breast Cancer Res Treat
; 177(2): 447-455, 2019 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-31236809
7.
Agreement between molecular subtyping and surrogate subtype classification: a contemporary population-based study of ER-positive/HER2-negative primary breast cancer.
Breast Cancer Res Treat
; 178(2): 459-467, 2019 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-31432367
8.
Written pretest information and germline BRCA1/2 pathogenic variant testing in unselected breast cancer patients: predictors of testing uptake.
Genet Med
; 21(1): 89-96, 2019 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29875420
9.
Longitudinal enumeration and cluster evaluation of circulating tumor cells improve prognostication for patients with newly diagnosed metastatic breast cancer in a prospective observational trial.
Breast Cancer Res
; 20(1): 48, 2018 06 08.
Artigo
Inglês
| MEDLINE | ID: mdl-29884204
10.
Assessment of early response biomarkers in relation to long-term survival in patients with HER2-negative breast cancer receiving neoadjuvant chemotherapy plus bevacizumab: Results from the Phase II PROMIX trial.
Int J Cancer
; 142(3): 618-628, 2018 02 01.
Artigo
Inglês
| MEDLINE | ID: mdl-28940389
11.
Immune gene expression and response to chemotherapy in advanced breast cancer.
Br J Cancer
; 118(4): 480-488, 2018 02 20.
Artigo
Inglês
| MEDLINE | ID: mdl-29370583
12.
BRCAsearch: written pre-test information and BRCA1/2 germline mutation testing in unselected patients with newly diagnosed breast cancer.
Breast Cancer Res Treat
; 168(1): 117-126, 2018 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-29164420
13.
DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriers.
PLoS Genet
; 10(4): e1004256, 2014 04.
Artigo
Inglês
| MEDLINE | ID: mdl-24698998
14.
Clinical and molecular complexity of breast cancer metastases.
Semin Cancer Biol
; 35: 85-95, 2015 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-26319607
15.
Efficacy and safety of olaparib monotherapy in germline BRCA1/2 mutation carriers with advanced ovarian cancer and three or more lines of prior therapy.
Gynecol Oncol
; 140(2): 199-203, 2016 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-26723501
16.
Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer.
JAMA
; 313(13): 1347-61, 2015 Apr 07.
Artigo
Inglês
| MEDLINE | ID: mdl-25849179
17.
Long-term prognosis of early-onset breast cancer in a population-based cohort with a known BRCA1/2 mutation status.
Breast Cancer Res Treat
; 144(1): 133-42, 2014 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-24477976
18.
High risk of in-breast tumor recurrence after BRCA1/2-associated breast cancer.
Breast Cancer Res Treat
; 147(3): 571-8, 2014 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-25187270
19.
Longitudinal molecular profiling elucidates immunometabolism dynamics in breast cancer.
Nat Commun
; 15(1): 3837, 2024 May 07.
Artigo
Inglês
| MEDLINE | ID: mdl-38714665
20.
Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers.
Hum Mol Genet
; 20(16): 3304-21, 2011 Aug 15.
Artigo
Inglês
| MEDLINE | ID: mdl-21593217